血必净注射液与安慰剂治疗重症社区获得性肺炎疗效的随机对照试验:研究结果与临床价值

Xuebijing injection versus placebo for critically ill patients with severe community-acquired pneumonia:a randomized controlled trial:research results and clinical value

本文针对发表于国际重症医学权威期刊Critical Care Medicine(CCM)的研究论文"血必净注射液与安慰剂治疗重症社区获得性肺炎疗效的随机对照试验"的研究结果及其临床价值进行介绍,同时附上两位同行专家对本研究的述评,供读者参考.

This article is based on the research paper named Xuebijing injection versus placebo for critically ill patients with severe community-acquired pneumonia:a randomized controlled trial which was published in Critical Care Medicine(CCM),introducing its study results and relevant clinical value.Moreover,we attached two peer experts'comments on this study for the readers'reference.